The stock market rally finally suffered substantial losses Thursday as the 10-year Treasury yields continue to rise. So, do we find ourselves staring down the barrel of a broad stock market retreat or a sector rotation? | |  | My day-to-day is busy, so I don't get to listen to earnings calls live very often. But for the sake of the Global Energy Crisis and our Fortune Research Weekly Watchlist I made an exception.
Coal producer Arch Resources kicked off the industry's earnings season by releasing Q3 results Tuesday morning.
By the numbers, it looked kind of "meh" at the outset, beating on revenue but missing on earnings per share.
Once the analysts started to ask questions, though, things got juicy…
And it's going to affect us in a big way. | | | | | | | | The last time the FDA made a call like this, one unsuspecting biotech ticker nearly tripled in eight days… And another cheap stock is poised to pop!
New Money Crew Head Trader Lance Ippolito bagged a 175% gain in a matter of eight days last time he spotted a trade just like this.
But Lance says that could be small potatoes compared to what's possible on this biotech stock.
And it's not too late to get in!
So be sure to check out how this latest FDA decision could be worth upward of $100,000,000, supercharging one $28 stock by the end of October… | | See the $100M Decision! | | |  | Winter Is Coming. But Our Energy Crisis Plays Are HOT | October 25, 2021 | For coal, we've got several key earnings reports coming out this week that will have a massive impact on some trades of ours. | | Continue Reading | | | | Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein. Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment. Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions. | | | | |
This email was sent to edwardlorilla1986.paxforex@blogger.com by WealthPress LLC
No comments:
Post a Comment